CPT 86652 EEEV Antibody Reimbursement

CPT code 86652 represents a laboratory immunoassay that detects antibodies to Eastern equine encephalitis virus (EEEV) in serum or cerebrospinal fluid. This specialized serologic test is clinically important for diagnosing or confirming EEEV infection, a rare but severe arboviral encephalitis. Nationally, access to and coverage for such targeted infectious disease testing affects public health surveillance, clinical management of suspected encephalitis, and laboratory preparedness for emerging or seasonal arboviral threats.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and sites of service, plus what to expect in payer coverage patterns and common billing considerations. The publication summarizes benchmarks where available, highlights policy and coverage elements relevant to infectious disease serology, and situates CPT 86652 within laboratory service lines used for neuroinfectious disease evaluation.

This report is written for a national audience and is intended to inform clinicians, laboratory managers, and policy professionals about the role of CPT 86652, typical service settings, and the payer landscape for specialized EEEV antibody testing. Data not available in the input will be noted explicitly in relevant sections.

Billing Code Overview

CPT code 86652 describes an immunoassay performed by a laboratory analyst to detect antibodies to Eastern equine encephalitis virus (EEEV) in a patient's serum or cerebrospinal fluid. This test is a serologic assay used to evaluate exposure to or immune response against EEEV.

Service type: Serologic immunoassay testing
Typical site of service: Clinical laboratory or hospital laboratory setting

Clinical Context

A middle-aged patient presents to the emergency department with acute onset fever, severe headache, photophobia, neck stiffness, and progressive confusion after recent outdoor exposure in an area with known mosquito activity. The emergency physician obtains bloodwork and cerebrospinal fluid (CSF) via lumbar puncture to evaluate for viral encephalitis. Because Eastern equine encephalitis virus (EEEV) is a potential etiology based on seasonal and epidemiologic risk factors, the laboratory performs an immunoassay to detect IgM and/or IgG antibodies to EEEV in serum and/or CSF. The sample is processed in the hospital or reference laboratory; results are reported to the ordering clinician to guide infectious disease consultation, public health notification, and supportive care decisions. Typical workflow steps include specimen collection (serum or CSF), proper labeling and transport to the laboratory, immunoassay testing by a virology/serology technologist, result verification by a laboratory director, and documentation in the medical record with notification to treating teams and local health authorities as required.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician interpretation/consultative component if the laboratory separates technical and professional charges.
`TC`

Taxonomy Code	Specialty	Notes
207Q00000X	Infectious Disease	Specialists who interpret serologic results and manage encephalitis.
207L00000X	Clinical Pathology	Pathologists and laboratory medicine physicians overseeing serology testing and result verification.
2080P0122X	Emergency Medicine	Emergency physicians ordering tests during acute presentations consistent with encephalitis.
363LF0000X	Laboratory Technician	Clinical laboratory technologists performing the immunoassay testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`A84.0`	Eastern equine encephalitis	Direct indication for EEEV serologic testing when clinically suspected.
`G04.90`	Encephalitis, unspecified	Common presenting diagnosis prompting broad encephalitis workup including EEEV antibody testing.
`G03.9`	Meningitis, unspecified	CSF or serum testing for arboviral antibodies may be included when meningitis is in the differential.
`R50.9`	Fever, unspecified	Fever with neurologic symptoms often leads to infectious serology panels that include EEEV.
`R41.0`	Disorientation, unspecified	Acute cognitive changes prompt evaluation for encephalitis and related serologies.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86769`	Antibodies; West Nile virus, IgG, IgM, single or combo	Often ordered in the same epidemiologic workup for arboviral encephalitis to evaluate alternative mosquito-borne causes.
`G0393`	Drug screen, definitive, any number of drugs, includes chromatography/mass spectrometry when performed	Performed in the differential diagnosis of altered mental status to exclude toxicologic causes alongside infectious testing.
`87633`	Infectious agent detection by nucleic acid (DNA or RNA); West Nile virus, amplified probe technique	Molecular testing for arboviral RNA may be performed in parallel or as follow-up to serology for definitive diagnosis.
`87449`	Infectious agent detection by nucleic acid (DNA or RNA), influenza virus, severe epidemic pathogens	Respiratory viral testing often performed concurrently in febrile encephalopathic patients to evaluate other viral etiologies.
`36415`	Collection of venous blood by venipuncture	Performed prior to serum-based immunoassay to obtain the specimen for `86652`.

OpenPayer

Summary & Overview

CPT 86652: EEEV Antibody Immunoassay in Serum or CSF